NCT01799603View on ClinicalTrials.gov

A Pharmacokinetic Study to Assess the Effect of Food in Healthy Male Participants Receiving TMC435

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Healthy
Interventions
DRUG

TMC435

TMC435, 100 milligram oral capsule will be administered on Day 1 of each treatment period, separated by washout period of 9 days.

Trial Locations (1)

Unknown

Toshima City

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY

NCT01799603 - A Pharmacokinetic Study to Assess the Effect of Food in Healthy Male Participants Receiving TMC435 | Biotech Hunter | Biotech Hunter